ZVSA · ZyVersa Therapeutics, Inc. · Analyst Estimates
$0.19
-0.13 (-40.51%)
At close · Jul 17
Return incl. dividend (before tax)
Going-concern doubt
— flagged May 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These uncertainties raise substantial doubt about our ability to continue as a going concern for 12 months after the issuance date of our financial statements.”View the 10-Q filed May 13, 2026
Market Cap
$833,880
Shares
8.10M
Volume · Jul 17
1.71M
Avg daily vol (3M)
5.63M
Analyst Estimates
Compare analyst forecasts for ZyVersa Therapeutics, Inc. across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Compiled consensus
These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.
Captured 2026-09-18 05:33 UTC · Publication dates shown per estimate · 4 metric / period groups
FY ending 2024-12-31
| Metric | Low | Average | High | Analyst count |
|---|---|---|---|---|
|
Revenue
Publication date not stated |
0
|
0
|
0
|
— |
|
Revenue
analysts
Publication date not stated |
— | — | — |
0
|
Q ending 2025-03-31
| Metric | Low | Average | High | Analyst count |
|---|---|---|---|---|
|
Revenue
Publication date not stated |
0
|
0
|
0
|
— |
|
Revenue
analysts
Publication date not stated |
— | — | — |
0
|